Analysts’ ratings for Health Catalyst (NASDAQ:HCAT) over the last quarter vary from bullish to bearish, as provided by 6 analysts. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. The 12-month price targets, analyzed by analysts, offer insights with an average target of $12.0, a high estimate of $16.00, and a low estimate of $7.00. Highlighting a 7.69% decrease, the current average has fallen from the previous average price target of $13.00. Investigating Analyst Ratings: An Elabor…